Biotechnology company engaged in the extraction and distribution of psychoactive compounds, and developing natural health care products.
HAVN Life Sciences has raised $7.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in July 2022.
HAVN Life Sciences's investors include Alpha Blue Ocean.
HAVN Life Sciences is headquartered in Vancouver, Canada.
Biotechnology company engaged in the extraction and distribution of psychoactive compounds, and developing natural health care products.
HAVN Life Sciences is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HAVN Life Sciences — Funding & Investors." VCBacked, July 21, 2022, https://www.vcbacked.co/company/havn-life-sciences. Accessed October 8, 2026.
VCBacked. (2022). HAVN Life Sciences — Funding & Investors. Retrieved October 8, 2026, from https://www.vcbacked.co/company/havn-life-sciences
{{cite web |title=HAVN Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/havn-life-sciences |website=VCBacked |access-date=October 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated